Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 1
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Acute Promyelocytic Leukemia or Acute Myeloid Leukemia with Mutated NPM1?
Cloobs-Venezia M, Dejesus J, Malusardi C, Auat M, Altube A. Cloobs-Venezia M, et al. Among authors: malusardi c. Turk J Haematol. 2022 Dec 1;39(4):262-263. doi: 10.4274/tjh.galenos.2022.2022.0220. Epub 2022 Aug 15. Turk J Haematol. 2022. PMID: 35965415 Free PMC article. No abstract available.
Detection of normal B cell precursors in lymph nodes samples.
Altube A, Marsol N, Rey Deutsch AC, Malusardi C, Sciaccaluga D, Cabral C, Auat M. Altube A, et al. Among authors: malusardi c. Int J Lab Hematol. 2023 Aug;45(4):592-595. doi: 10.1111/ijlh.14037. Epub 2023 Feb 16. Int J Lab Hematol. 2023. PMID: 36797825 No abstract available.
A drug potency signature links progression of chronic lymphocytic leukemia to mitochondria-related stress responses and metabolic reprogramming under hypoxia.
Kornblihtt LI, Cabral Lorenzo MC, Gil Folgar ML, Minissale CJ, Malusardi C, Rojas F, Lombardo T, Blanco GA. Kornblihtt LI, et al. Among authors: malusardi c. Toxicol Appl Pharmacol. 2020 Jul 1;398:115016. doi: 10.1016/j.taap.2020.115016. Epub 2020 Apr 20. Toxicol Appl Pharmacol. 2020. PMID: 32325063
An Extensive Quality Control and Quality Assurance (QC/QA) Program Significantly Improves Inter-Laboratory Concordance Rates of Flow-Cytometric Minimal Residual Disease Assessment in Acute Lymphoblastic Leukemia: An I-BFM-FLOW-Network Report.
Maurer-Granofszky M, Schumich A, Buldini B, Gaipa G, Kappelmayer J, Mejstrikova E, Karawajew L, Rossi J, Suzan AÇ, Agriello E, Anastasiou-Grenzelia T, Barcala V, Barna G, Batinić D, Bourquin JP, Brüggemann M, Bukowska-Strakova K, Burnusuzov H, Carelli D, Deniz G, Dubravčić K, Feuerstein T, Gaillard MI, Galeano A, Giordano H, Gonzalez A, Groeneveld-Krentz S, Hevessy Z, Hrusak O, Iarossi MB, Jáksó P, Kloboves Prevodnik V, Kohlscheen S, Kreminska E, Maglia O, Malusardi C, Marinov N, Martin BM, Möller C, Nikulshin S, Palazzi J, Paterakis G, Popov A, Ratei R, Rodríguez C, Sajaroff EO, Sala S, Samardzija G, Sartor M, Scarparo P, Sędek Ł, Slavkovic B, Solari L, Svec P, Szczepanski T, Taparkou A, Torrebadell M, Tzanoudaki M, Varotto E, Vernitsky H, Attarbaschi A, Schrappe M, Conter V, Biondi A, Felice M, Campbell M, Kiss C, Basso G, Dworzak MN, On Behalf Of I-Bfm-Flow-Network. Maurer-Granofszky M, et al. Among authors: malusardi c. Cancers (Basel). 2021 Dec 6;13(23):6148. doi: 10.3390/cancers13236148. Cancers (Basel). 2021. PMID: 34885257 Free PMC article.